Join today’s most successful investors and
discover the Next Super Stock….
…at the livestream event everyone’s taking about:
Wall Street Reporter’s NEXT SUPER STOCK LIVE!
November 14, 2019 Conference Presenters:
12:30EST – Nightfood Holdings, Inc. (OTC: NGTF)
Nightfoood Holdings, Inc. (OTC: NGTF) is an innovative ice cream start-up targeting the $50 billion nighttime snackers market.
CEO Sean Folkson will be discussing NGTF’s unique market opportunity, and how NGTF is following the successful playbook of other innovative food & beverage start-up brands, that have become billion dollar giants in recent years.
12:50EST – NexTech AR Solutions, Inc. (OTC: NEXCF)
Returning for an encore presentation from September’s NEXT SUPER STOCK conference is Evan Gappelberg, CEO of NexTech AR Solution Corp.
NEXCF stock has increased from $0.52 at the time of the company’s August 15, 2019 debut at the NEXT SUPER STOCK conference to a recent high of $1.27.
NexTech (OTC: NEXCF) is one of the leaders in the rapidly growing Augmented Reality technology industry, estimated to hit $120 billion by 2022, according to Statista (and the only “pure play” AR stock).
Evan will update investors on NEXCF’s rapid progress since last month’s conference presentation, including: record revenue growth, launch of the AR online advertising network, the company’s latest AR tech innovations for image capture, and more.
1:10EST – CytoDyn, Inc. (OTC: CYDY)
CytoDyn, Inc. (OTC: CYDY) CEO Nader Pourhassan, Ph.D, will be making his second NEXT SUPER STOCK conference appearance, which is highly anticipated by the thousands of investors worldwide who follow CYDY.
Dr. Pourhassan will be discussing the company’s latest progress for its leronlimab monoclonal antibody drug platform, and it’s pipeline targeting HIV, multiple cancer indications, and immune-mediated illnesses, such as GvHD and NASH, which have blockbuster revenue potential.
CYDY’s lead drug candidate, leronlimab (PRO 140) for treating HIV, is expected to receive FDA approval in mid 2020. Investors attention is also on the possibility of CytoDyn’s HIV monotherapy potential receiving FDA approval as label expansion, potentially in 2021. CytoDyn’s monotherapy is a potential “game changer” in HIV treatment, requiring only once-weekly dose which could be self-administered.
A question & answer session will follow the presentation, and investors are invited to submit questions in advance, or during the live session.
Here’s a few examples of past presenters at Wall Street Reporter events, and the subsequent increase in their stock price:
+1,393% Heska Corp (NASDAQ: HSKA)
+1,068% Taser International (NASDAQ: TASR)
+1,100% TZ Limited (ASX: TZ)
+ 1,280% Simulation Plus (NASDAQ: SLP)
+ 520% Zaio Corp. (TSX: ZAO)
+ 720% Hana Bioscience (NASDAQ: HNAB)
+ 725% Biosante Pharmaceuticals (NASDAQ: BPAX)
+ 845% ECU Silver Mining (TSX: ECU)
ABOUT THE EVENT
NEXT SUPER STOCK Live! is Wall Street Reporter’s flagship investor conference series featuring presentations by a select group of companies which are at key inflection points, and at the threshold of explosive growth.
CATALYSTS for TRANSFORMATIONAL GROWTH
What makes the NEXT SUPER STOCK Live! conference unique, is all the presenting companies have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead.
Examples of value creation catalysts include: Major new product launches, mergers & acquisitions, new resource discoveries, FDA approvals, and other value creation events – which transform companies and create SUPER STOCKS.
Just as importantly as their exciting business fundamentals – each presenting company also benefits from high profile marketing to Wall Street Reporter’s global institutional investor audience over the coming months – resulting in increased market awareness for their stocks. Watching this livestream event, gives investors an opportunity to get in on the ground floor of what could be the “Next Super Stock” – before they are discovered by Wall Street.
UNIQUE EVENT FORMAT
NEXT SUPER STOCK Live! is a 1-hour online-only livestream event, featuring presentations from CEO’s of just three selected companies. The fast-paced 1-hour event format, features 15 minute CEO presentations followed by 5-minute Q&A. (The event takes place from 12PM-1PM EST, allowing for investment professionals to watch during their lunch break in the trading day.) Event attendees gain maximum value, in minimum of time.
TRACK RECORD of SUCCESS
Over the past 20 years, Wall Street Reporter’s investor conferences have earned a unique reputation for showcasing high-potential stocks – many of which go on to deliver triple-digit gains, and become Super Stocks.
Event attendees include, leading fund managers, analysts, investment bankers, family offices, as well as sophisticated individual investors. If you’re a finance professional in the small-cap space, chances are your peers will be attending this live online event – shouldn’t you join them?
Presenting companies are announced 3 days before the event.
You’ll have a first-hand opportunity to watch live presentation from CEO’s of today’s most exciting companies.
Watch the fast-paced CEO presentations, and gain an insider perspective on the company’s unique opportunities and challenges, and learn about their upside potential – ahead of the crowd.
Interested in having YOUR company as a presenter at Wall Street Reporter’s next event?
Call Mr. Jack Marks 212-871-2057 ext. 7